Fig. 6

In vivo evaluation of the nanosystem in a BALB/c mouse breast cancer model. (a) Body weight changes and (b) Tumor volume changes in mice during and after the treatment period. (c) Tumor growth inhibition efficiency for each treatment group. (d) Number of mice with lung metastases in each group after treatment. * P < 0.05, ** P < 0.01, *** P < 0.001 (n = 8)